Compare Stocks: RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MGA Magna International	$64.12 +1.1%	$67.48	$43.11 ▼ $73.22	$16.95B	1.45	1.56 million shs	951 shs
NVDA NVIDIA	$213.87 +0.8%	$213.90	$164.27 ▼ $236.54	$5.16T	2.22	156.16 million shs	3.05 million shs
RHHBY Roche	$54.95 +0.3%	$54.55	$39.50 ▼ $60.85	$349.11B	0.48	2.27 million shs	1.12 million shs
RXRX Recursion Pharmaceuticals	$3.28 +1.1%	$3.27	$2.77 ▼ $7.18	$1.75B	1.07	17.80 million shs	68,426 shs
SERV Serve Robotics	$4.33 0.0%	$5.03	$4.27 ▼ $18.64	$377.97M	1.25	4.71 million shs	16,983 shs
SHAK Shake Shack	$58.84 +1.0%	$65.93	$51.60 ▼ $107.46	$2.52B	1.66	1.78 million shs	1,792 shs
SNY Sanofi	$42.87 +1.1%	$43.95	$40.89 ▼ $52.68	$103.56B	0.35	3.40 million shs	16,294 shs

10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MGA Magna International	-2.31%	-4.80%	-9.75%	-2.32%	+35.28%
NVDA NVIDIA	+0.57%	-6.01%	-5.77%	+3.67%	+19.36%
RHHBY Roche	+0.26%	+1.62%	+0.78%	+7.61%	+34.08%
RXRX Recursion Pharmaceuticals	-4.99%	-5.81%	+2.53%	+4.18%	-32.08%
SERV Serve Robotics	-2.26%	-11.63%	-13.23%	-35.28%	-64.54%
SHAK Shake Shack	-8.61%	-13.86%	-22.37%	-0.92%	-42.67%
SNY Sanofi	-2.15%	-1.74%	-3.02%	-0.24%	-9.05%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MGA Magna International	$64.12 +1.1%	$67.48	$43.11 ▼ $73.22	$16.95B	1.45	1.56 million shs	951 shs
NVDA NVIDIA	$213.87 +0.8%	$213.90	$164.27 ▼ $236.54	$5.16T	2.22	156.16 million shs	3.05 million shs
RHHBY Roche	$54.95 +0.3%	$54.55	$39.50 ▼ $60.85	$349.11B	0.48	2.27 million shs	1.12 million shs
RXRX Recursion Pharmaceuticals	$3.28 +1.1%	$3.27	$2.77 ▼ $7.18	$1.75B	1.07	17.80 million shs	68,426 shs
SERV Serve Robotics	$4.33 0.0%	$5.03	$4.27 ▼ $18.64	$377.97M	1.25	4.71 million shs	16,983 shs
SHAK Shake Shack	$58.84 +1.0%	$65.93	$51.60 ▼ $107.46	$2.52B	1.66	1.78 million shs	1,792 shs
SNY Sanofi	$42.87 +1.1%	$43.95	$40.89 ▼ $52.68	$103.56B	0.35	3.40 million shs	16,294 shs

10 Best Stocks to Own - Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MGA Magna International	-2.31%	-4.80%	-9.75%	-2.32%	+35.28%
NVDA NVIDIA	+0.57%	-6.01%	-5.77%	+3.67%	+19.36%
RHHBY Roche	+0.26%	+1.62%	+0.78%	+7.61%	+34.08%
RXRX Recursion Pharmaceuticals	-4.99%	-5.81%	+2.53%	+4.18%	-32.08%
SERV Serve Robotics	-2.26%	-11.63%	-13.23%	-35.28%	-64.54%
SHAK Shake Shack	-8.61%	-13.86%	-22.37%	-0.92%	-42.67%
SNY Sanofi	-2.15%	-1.74%	-3.02%	-0.24%	-9.05%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MGA Magna International	2.42	Hold	$67.87	7.06% Upside
NVDA NVIDIA	3.02	Buy	$324.34	52.87% Upside
RHHBY Roche	2.50	Moderate Buy	$60.00	9.20% Upside
RXRX Recursion Pharmaceuticals	2.20	Hold	$8.06	148.77% Upside
SERV Serve Robotics	2.75	Moderate Buy	$14.77	241.03% Upside
SHAK Shake Shack	2.57	Moderate Buy	$89.71	54.50% Upside
SNY Sanofi	2.38	Hold	$49.50	16.75% Upside

Current Analyst Ratings Breakdown

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/15/2026	MGA Magna International	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Neutral	$77.00 ➝ $72.00
9/10/2026	NVDA NVIDIA	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/10/2026	SNY Sanofi	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/10/2026	RHHBY Roche	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
9/9/2026	NVDA NVIDIA	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral ➝ Overweight	$300.00
9/9/2026	SHAK Shake Shack	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
9/9/2026	NVDA NVIDIA	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
9/8/2026	RHHBY Roche	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform
9/8/2026	SNY Sanofi	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sector Perform
9/8/2026	SHAK Shake Shack	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$89.00
9/8/2026	SHAK Shake Shack	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$89.00

(Data available from 9/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MGA Magna International	$42.01B	0.40	$11.50 per share	5.51	$45.81 per share	1.38
NVDA NVIDIA	$215.94B	23.68	$4.75 per share	44.66	$9.50 per share	22.33
RHHBY Roche	$76.45B	4.58	$3.61 per share	15.22	$7.18 per share	7.65
RXRX Recursion Pharmaceuticals	$74.68M	23.23	N/A	N/A	$2.14 per share	1.51
SERV Serve Robotics	$2.65M	141.68	N/A	N/A	$4.71 per share	0.92
SHAK Shake Shack	$1.45B	1.72	$3.60 per share	16.12	$12.97 per share	4.48
SNY Sanofi	$49.35B	2.08	$6.92 per share	6.13	$33.27 per share	1.27

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MGA Magna International	$829M	$2.76	22.97	8.07	0.69	1.80%	15.04%	5.93%	10/30/2026 (Estimated)
NVDA NVIDIA	$120.07B	$7.91	26.82	13.84	1.65	63.66%	96.04%	71.00%	11/18/2026 (Estimated)
RHHBY Roche	$15.55B	N/A	N/A	16.65	3.50	N/A	N/A	N/A	N/A
RXRX Recursion Pharmaceuticals	-$644.76M	-$1.04	N/A	N/A	N/A	-945.94%	-50.41%	-38.25%	11/4/2026 (Estimated)
SERV Serve Robotics	-$101.36M	-$2.45	N/A	N/A	N/A	-2,315.80%	-55.34%	-52.06%	11/11/2026 (Estimated)
SHAK Shake Shack	$45.72M	$0.94	61.77	43.66	7.02	2.56%	9.29%	2.71%	10/29/2026 (Estimated)
SNY Sanofi	$8.84B	$1.91	22.20	8.02	1.30	8.66%	14.19%	7.95%	10/30/2026 (Estimated)

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/26/2026	Q2 2027	NVDA NVIDIA	$2.09	$2.22	+$0.13	$2.46	$92.27 billion	$96.22 billion
8/6/2026	Q2 2026	SERV Serve Robotics	-$0.69	-$0.80	-$0.11	-$0.80	$3.51 million	$3.24 million
8/5/2026	Q2 2026	RXRX Recursion Pharmaceuticals	-$0.24	-$0.25	-$0.01	-$0.25	$10.97 million	$7.67 million
8/5/2026	Q2 2026	SHAK Shake Shack	$0.3055	$0.43	+$0.1245	$0.37	$417.18 million	$417.62 million
7/31/2026	Q2 2026	MGA Magna International	$1.53	$1.86	+$0.33	$1.72	$10.63 billion	$10.84 billion
7/30/2026	Q2 2026	SNY Sanofi	N/A	$2.41	N/A	$0.17	N/A	$13.36 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MGA Magna International	$1.98	3.12%	-9.47%	71.74%	6 Years
NVDA NVIDIA	$1.00	0.47%	+14.87%	12.64%	1 Years
RHHBY Roche	$0.97	1.77%	N/A	N/A	N/A
RXRX Recursion Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
SERV Serve Robotics	N/A	N/A	N/A	N/A	N/A
SHAK Shake Shack	N/A	N/A	N/A	N/A	N/A
SNY Sanofi	$1.76	4.15%	+6.46%	92.15%	N/A

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/26/2026	NVDA NVIDIA	quarterly	$0.25	0.46%	9/10/2026	9/10/2026	10/1/2026
7/31/2026	MGA Magna International	quarterly	$0.4950	2.82%	8/14/2026	8/14/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MGA Magna International	0.38	1.22	0.88
NVDA NVIDIA	0.14	4.59	3.85
RHHBY Roche	0.72	1.38	1.12
RXRX Recursion Pharmaceuticals	0.01	5.03	5.03
SERV Serve Robotics	N/A	12.83	12.83
SHAK Shake Shack	0.43	1.67	1.64
SNY Sanofi	0.21	0.99	0.64

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MGA Magna International	67.49%
NVDA NVIDIA	65.27%
RHHBY Roche	N/A
RXRX Recursion Pharmaceuticals	89.06%
SERV Serve Robotics	N/A
SHAK Shake Shack	86.07%
SNY Sanofi	14.03%

Insider Ownership

Company	Insider Ownership
MGA Magna International	0.50%
NVDA NVIDIA	3.94%
RHHBY Roche	N/A
RXRX Recursion Pharmaceuticals	6.65%
SERV Serve Robotics	5.00%
SHAK Shake Shack	8.32%
SNY Sanofi	1.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MGA Magna International	156,000	264.85 million	263.52 million	Optionable
NVDA NVIDIA	42,000	24.10 billion	23.15 billion	Optionable
RHHBY Roche	103,249	6.37 billion	N/A	Not Optionable
RXRX Recursion Pharmaceuticals	600	535.34 million	499.74 million	Optionable
SERV Serve Robotics	67	86.71 million	82.37 million	N/A
SHAK Shake Shack	13,873	42.80 million	39.24 million	Optionable
SNY Sanofi	74,846	2.42 billion	2.40 billion	Optionable

RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Headlines

Recent News About These Companies

Sanofi to Acquire 26.4% Stake in Cheplapharm

September 14 at 2:41 PM | finance.yahoo.com

Sanofi To Receive 26.4% Stake In Cheplapharm For Mature Medicines

September 14 at 2:41 PM | rttnews.com

Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines

September 14 at 9:03 AM | globenewswire.com

Tidal Investments LLC Acquires 29,283 Shares of Sanofi $SNY

September 13 at 4:24 AM | marketbeat.com

Sanofi Partners With USA Pickleball On COVID-19 Protection Campaign

September 10, 2026 | rttnews.com

Archford Capital Strategies LLC Invests $1.42 Million in Sanofi $SNY

September 10, 2026 | marketbeat.com

Astra, Roche win new outperform ratings as RBC initiates EU pharma coverage

September 9, 2026 | msn.com

Sanofi (NASDAQ:SNY) Rating Increased to Buy at Wall Street Zen

August 29, 2026 | marketbeat.com

SNY Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?

August 28, 2026 | zacks.com

Sanofi (NASDAQ:SNY) Receives Average Rating of "Hold" from Analysts

August 28, 2026 | marketbeat.com

US FDA approves updated COVID vaccines for 2026-27 season

August 27, 2026 | reuters.com

Sanofi stock steadies after strong Q2 2026 and upgraded guidance

August 21, 2026 | ad-hoc-news.deA

Why the Amlitelimab Setback Isn’t Enough to Sink Sanofi’s Multi-Billion Dollar Engine

August 10, 2026 | insidermonkey.com

Why the Amlitelimab Setback Isn’t Enough to Sink Sanofi’s Multi-Billion Dollar Engine

August 10, 2026 | finance.yahoo.com

Sanofi 2026 Q2 - Results - Earnings Call Presentation

August 7, 2026 | seekingalpha.com

Sanofi Says EU Expands MenQuadfi Approval

August 5, 2026 | finance.yahoo.com

Sanofi’s MenQuadfi approved in EU for infants against meningococcal disease

August 5, 2026 | msn.com

Why Investors Should Look at L3Harris, Cenovus, and Sanofi

August 5, 2026 | baystreet.ca

Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease

August 4, 2026 | manilatimes.netM

Press Release: Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease

August 4, 2026 | globenewswire.com

Sanofi SA (SNY) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Upgraded Guidance ...

August 1, 2026 | sg.finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Company Descriptions

Magna International NYSE:MGA

$64.11 +0.70 (+1.10%)

As of 09:33 AM Eastern

Magna International Inc. designs, engineers, and manufactures components, assemblies, systems, subsystems, and modules for original equipment manufacturers of vehicles and light trucks worldwide. It operates through four segments: Body Exteriors & Structures, Power & Vision, Seating Systems, and Complete Vehicles. The Body Exteriors & Structures segment provides body and chassis system, battery enclosures, and engineering and testing; and exteriors, including fascia and trims, front end modules, integration panels, liftgate modules, active aerodynamics, engineered glass, running boards, truck bed access products, breakthrough lightings, side doors, and greenhouse products. The Power & Vision segment offers electric drive systems and components, such as emotors, inverters, onboard chargers, gearboxes, and e-clutch; dedicated hybrid drives, dual and hybrid dual clutch, and manual transmissions; AWD/4WD products and rear drive modules; transmission, driveline components, and ICE; far camera module, remote camera heads, interior sensing camera, radars, thermal sensing, and domain controllers; interior and exterior mirrors, camera monitoring system driver/occupant monitoring systems, and smart actuators; forward and rear lighting, and lit grilles/panels/displays; latching system, door modules, charge port doors, power system, hinges, and door handles; and modular and textile folding roofs, and hard and soft tops. The Seating Systems segment provides seat structures, mechanism and hardware solutions, and foam and trim products. The Complete Vehicles segment offers vehicle engineering and manufacturing services. Magna International Inc. was founded in 1957 and is headquartered in Aurora, Canada.

NVIDIA NASDAQ:NVDA

$213.87 +1.70 (+0.80%)

As of 09:33 AM Eastern

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

Roche OTCMKTS:RHHBY

$54.95 +0.15 (+0.26%)

As of 09/15/2026 04:00 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Recursion Pharmaceuticals NASDAQ:RXRX

$3.28 +0.04 (+1.08%)

As of 09:33 AM Eastern

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Serve Robotics NASDAQ:SERV

$4.33 0.00 (-0.05%)

As of 09:33 AM Eastern

Serve Robotics Inc. designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. It builds self-driving delivery robots. The company was formerly known as Patricia Acquisition Corp. and changed its name to Serve Robotics Inc. in July 2023. Serve Robotics Inc. was founded in 2017 and is based in Redwood City, California.

Shake Shack NYSE:SHAK

$58.84 +0.57 (+0.99%)

As of 09:33 AM Eastern

Shake Shack Inc. owns, operates, and licenses Shake Shack restaurants (Shacks) in the United States and internationally. Its Shacks offers hamburgers, chicken, hot dogs, crinkle cut fries, shakes, frozen custard, beer, wine, and other products. The company was founded in 2001 and is headquartered in New York, New York.

Sanofi NASDAQ:SNY

$42.87 +0.47 (+1.12%)

As of 09:33 AM Eastern

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Earnings

Compare Dividends

Latest RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

RXRX, NVDA, SERV, SNY, RHHBY, SHAK, and MGA Company Descriptions

Magna International NYSE:MGA

NVIDIA NASDAQ:NVDA

Roche OTCMKTS:RHHBY

Recursion Pharmaceuticals NASDAQ:RXRX

Serve Robotics NASDAQ:SERV

Shake Shack NYSE:SHAK

Sanofi NASDAQ:SNY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools